Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-24-084945

Options or other derivatives

  • Director acquired 72,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
McKenna Mark C. Director 2024-07-17 Grant or award · Option (right to buy) +72,500 72,500 D: show line 1 in the form
Loading xslF345X05/ownership.xml…